Stryker Neurovascular Trevo ProVue Retriever

It is indicated for use to restore blood flow in the neurovasculature by removing thrombus: - for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, large vessel occlusion (LVO), and smaller core infarcts who have first received intravenous tissue plasminogen activator (IV t-PA). Endovascular therapy should start within 6 hours of symptom onset. - for patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for IV t-PA or who fail IV t-PA therapy are candidates for treatment. - for the treatment of acute ischemic stroke to reduce disability in patients with a persistent, proximal anterior circulation, LVO of the ICA or MCA-M1 segments with smaller core infarcts (0-50cc for age <80 years, 0-20cc for age ≥80 years). Endovascular therapy should start within 6-24 hours of time last seen well in patients who are ineligible for IV t-PA or who fail IV t-PA therapy.